activity
20232026
most citedACEGEN: Reinforcement learning of generative chemical agents for drug discovery

3 citations · 4 across the 5 of their papers we have counts for

collaborators

5 papers

cs.LG2026

Structure-guided molecular design with contrastive 3D protein-ligand learning

Carles Navarro, Philipp Tholke, Gianni de Fabritiis

Structure-based drug discovery faces the dual challenge of accurately capturing 3D protein-ligand interactions while navigating ultra-large chemical spaces to identify syntheticall…

q-bio.BM2025

Speak to a Protein: An Interactive Multimodal Co-Scientist

Carles Navarro, Mariona Torrens, Philipp Thölke +2

Building a working mental model of a protein typically requires weeks of reading, cross-referencing crystal and predicted structures, and inspecting ligand complexes, an effort tha…

q-bio.BM2024★ 1 cited

On Machine Learning Approaches for Protein-Ligand Binding Affinity Prediction

Nikolai Schapin, Carles Navarro, Albert Bou +1

Binding affinity optimization is crucial in early-stage drug discovery. While numerous machine learning methods exist for predicting ligand potency, their comparative efficacy rema…

cs.LG2024★ 3 cited

ACEGEN: Reinforcement learning of generative chemical agents for drug discovery

Albert Bou, Morgan Thomas, Sebastian Dittert +10

In recent years, reinforcement learning (RL) has emerged as a valuable tool in drug design, offering the potential to propose and optimize molecules with desired properties. Howeve…

q-bio.BM2023

Top-down machine learning of coarse-grained protein force-fields

Carles Navarro, Maciej Majewski, Gianni de Fabritiis

Developing accurate and efficient coarse-grained representations of proteins is crucial for understanding their folding, function, and interactions over extended timescales. Our me…